P134

J. Nanopharmaceutics Drug Delivery 2014, 2, 1-11. 

Enhanced pulmonary administration of amphotericin B loaded in PEG-g-PLA nanoparticles: in vitro proof-of-concept and susceptibility against Candida spp. and Aspergillus spp.

Aoun, V. | Duval, C. | Pagniez, F. | Rabanel, J.-M. | Le Pape, P. | Roullin, V. G. | Leclair, G. | Hildgen, P.

P133

Anticancer Res. 2014, 34, 4797-4806. 

Cucurbitacin-D-induced CDK1 mRNA Up-regulation Causes Proliferation Arrest of a Non-small Cell Lung Carcinoma Cell Line (NSCLC-N6).

Jacquot, C | Rousseau, B | Carbonnelle, D | Chinou, I | Malleter, M | Tomasoni, C | Roussakis, C.

P132

Eur. J. Med. Chem. 2014, 81, 378-393.

Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents - Part III.

Ronga, L | Del Favero, M. | Cohen, A. | Soum, C. | Le Pape, P. | Savrimoutou, S. | Pinaud, N. | Mullié, C. | Daulouede, S. | Vincendeau, P. | Farvacques, N. | Agnamey, P. | Pagniez, P. | Hutter, S. | Azas, N. | Sonnet, P. | Guillon, J.

P131

Bioorg. Med. Chem. Lett. 2014, 24, 5037-5040.

Synthesis of new pyridazino[4,5-b]indol-4-ones and pyridazin-3(2H)-one analogs as DYRK1A inhibitors.

Bruel, A. | Bénéteau, R. | Chabanne, M. | Lozach, O. | Le Guével, R. | Ravache, M. | Bénédetti, H. | Meijer, L. | Logé, C. | Robert, J.-M.

P130

Transpl. Infect. Dis. 2014.

Multifocal phaeohyphomycosis caused by Exophiala xenobiotica in a kidney transplant recipient.

Palmisano, A. | Morio, F. | Le Pape, P. | Degli Antoni A. M., Ricci, R. | Zucchi, A. | Vaglio, A. | Piotti, G. | Antoniotti, R. | Cremaschi, E. | Buzio, C. | Maggiore, U.

P129

Actualités permanentes en Microbiologie Clinique. 2014.

Mécanismes de la résistance des Candida aux antifongiques.

Morio, F. | Le Pape, P.

P128

Journal des Anti-infectieux. 2014.

Mutations du gène codant la Dihydroptéroate synthase (DHPS) et résistance aux traitements anti-Pneumocystis : Mythe ou réalité ?

Morio, F.

P127

Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.

Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.

Defaux, J. | Antoine, M. | Logé, C. | Le Borgne, M. | Schuster, T. | Seipelt, I. | Aicher, B. | Teifel, M. | Günther, E. | Gerlach, M. | Marchand, P.

P126

Sci. Rep. 2014, 4:3977.

Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells.

Sakanyan, V. | Angelini, M. | Le Béchec, M. | Lecocq, M.-F. | Benaiteau, F. | Rousseau, B. | Gyulkhandanyan, A. | Gyulkhandanyan, L. | Logé, C. | Reiter, E. | Roussakis, C. | Fleury, F.

doi: 10.1038/srep03977.

P125

Eur. J. Org. Chem. 2014, 7, 1487-1495.

Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings.

Montoir, D. | Tonnerre, A. | Duflos, M. | Bazin, M.-A.

P124

ChemMedChem 2014, 9, 217-232.

Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. 

Defaux, J. | Antoine, M. | Le Borgne, M. | Schuster, T. | Seipelt, I. | Aicher, B. | Teifel, M. | Günther, E. | Gerlach, M. | Marchand, P.